STAT+: Here are the best biopharma CEOs of 2023
1 year 7 months ago
Adam's Take, Biotech, biotechnology, Eli Lilly, Novo Nordisk, Pharmaceuticals, STAT+
The biotech news you missed from the weekend
1 year 7 months ago
Biotech, Business, Health, Pharma, Politics, The Readout, biotechnology, Cancer, drug development, drug pricing, FDA, finance, genetics, Pharmaceuticals, Research
Eli Lilly’s latest $1.4 billion deal might come unglued
1 year 7 months ago
Biotech, Business, Health, Pharma, Politics, The Readout, biotechnology, drug development, drug prices, drug pricing, finance, Pharmaceuticals, Research, vaccines
STAT+: AbbVie purchases neuroscience developer Cerevel for $8.7 billion
1 year 8 months ago
Biotech, AbbVie, biotechnology, STAT+
STAT+: Do GLP-1s have a future treating alcoholism?
1 year 8 months ago
Biotech, Business, Health, Health Care, Pharma, The Readout, biotechnology, drug development, drug prices, drug pricing, FDA, finance, genetics, Pharmaceuticals
STAT+: AbbVie buys Immunogen, maker of targeted cancer drugs, for $10 billion
1 year 8 months ago
Biotech, biotechnology, Cancer, STAT+
STAT+: Cassava pulled back the curtain on its Alzheimer’s study — and revealed insurmountable problems
1 year 9 months ago
Adam's Take, Biotech, Alzheimer’s, biotechnology, STAT+
STAT+: Regeneron gene therapy improves hearing in child
1 year 9 months ago
Biotech, Business, Health, Health Care, The Readout, biotechnology, Congress, drug development, FDA, finance, Pharmaceuticals, policy
Here are the 10 drugs that will be up first for Medicare price negotiation
1 year 11 months ago
Biotech, Politics, CMS, drug prices, health care policy, Joe Biden, Medicare, White House
STAT+: Gene therapy eyedrops restored a boy’s sight. Similar treatments could help millions
2 years 1 week ago
Biotech, biotechnology